Vanda Pharmaceuticals, Inc. (VNDA) Tops Q3 EPS by 8c
Tweet
Share
E-mailGet Alerts VNDA Hot Sheet
Price: $5.03 -3.08%
Financial Fact:
Intangible asset amortization: 2.94M
Today's EPS Names:
OFLX, NMRD, VAXX, More
Financial Fact:
Intangible asset amortization: 2.94M
Today's EPS Names:
OFLX, NMRD, VAXX, More
Join SI Premium – FREE
Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) reported Q3 EPS of ($0.19), $0.08 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $8.3 million versus the consensus estimate of $8.3 million.
For earnings history and earnings-related data on Vanda Pharmaceuticals, Inc. (VNDA) click here.
For earnings history and earnings-related data on Vanda Pharmaceuticals, Inc. (VNDA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Brookfield Wealth Solutions Ltd. (BNT) Reports Q2 EPS of $0.07
- Hitachi Ltd. (HIT) Misses Q2 EPS by 7c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
